All Phenotypes Cry1<tm1Jhjh> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Cry1^tm1Jhjh/Cry1^tm1Jhjh	involves: 129P2/OlaHsd * C57BL/6	MGI:4943715
cx2	Cry1^tm1Jhjh/Cry1^tm1Jhjh Per2^tm1Brd/Per2^tm1Brd	involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6	MGI:3522462
cx3	Cry1^tm1Jhjh/Cry1⁺ Cry2^tm1Jhjh/Cry2^tm1Jhjh	involves: 129P2/OlaHsd * C57BL/6	MGI:4943717
cx4	Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:4943718
cx5	Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2^tm1Jhjh	involves: 129P2/OlaHsd * C57BL/6	MGI:4943719

Allelic Composition	Cry1^tm1Jhjh/Cry1^tm1Jhjh
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cry1^tm1Jhjh mutation (0 available); any Cry1 mutation (36 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

shortened circadian behavior period ( J:54241 )

• under dark:dark conditions

• however, light entrainment of locomotor activity is normal

Allelic Composition	Cry1^tm1Jhjh/Cry1^tm1Jhjh Per2^tm1Brd/Per2^tm1Brd
Genetic Background	involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cry1^tm1Jhjh mutation (0 available); any Cry1 mutation (36 available)
Per2^tm1Brd mutation (1 available); any Per2 mutation (73 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

arrhythmic circadian behavior persistence ( J:79492 )

• when placed in DD, double homozygotes are completely arrhythmic (total absence of a circadian clock)

Allelic Composition	Cry1^tm1Jhjh/Cry1⁺ Cry2^tm1Jhjh/Cry2^tm1Jhjh
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cry1^tm1Jhjh mutation (0 available); any Cry1 mutation (36 available)
Cry2^tm1Jhjh mutation (0 available); any Cry2 mutation (42 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal circadian behavior period ( J:54241 )

• period is intermediate to single homozygotes

Allelic Composition	Cry1^tm1Jhjh/Cry1^tm1Jhjh Cry2^tm1Jhjh/Cry2⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal circadian behavior ( J:54241 )

• under dark:dark conditions, mice exhibit a shorter free-running rhythm that gradually progresses into arrhythmicity unlike in wild-type mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

abnormal circadian behavior period ( J:54241 )

• following entrainment to a light:dark regime, mice abruptly adapt to a new situation by starting wheel running as soon as light is off and expanding their period of fragmented activity unlike wild-type mice

arrhythmic circadian behavior persistence ( J:54241 )

• under dark:dark conditions

• however, mice exhibit normal circadian rhythm under light:dark conditions

immune system

abnormal T cell activation ( J:159504 )

• mice exhibit an increase in activated T cells compared with wild-type mice

increased circulating interleukin-1 beta level ( J:159504 )

• following treatment with anti-CII antibodies

increased circulating interleukin-6 level ( J:159504 )

• following treatment with anti-CII antibodies

• however, treatment with anti-TNF-alpha antibodies reduces serum levels of IL6 induced by anti-CII antibodies

increased circulating tumor necrosis factor level ( J:159504 )

• following treatment with anti-CII antibodies

• however, treatment with anti-TNF-alpha antibodies reduces serum levels of TNF-alpha induced by anti-CII antibodies

increased tumor necrosis factor secretion ( J:159504 )

• in splenocyte

increased susceptibility to induced arthritis ( J:159504 )

• following treatment with anti-CII antibodies, mice exhibit increased arthritis score and serum levels of TNF-alpha, IL1beta, IL6, and MMP3 compared with wild-type mice

• however, treatment with anti-TNF-alpha antibodies reduces induced arthritis score and levels of TNF-alpha, IL6, and MMP3

skeleton

increased susceptibility to induced arthritis ( J:159504 )

• following treatment with anti-CII antibodies, mice exhibit increased arthritis score and serum levels of TNF-alpha, IL1beta, IL6, and MMP3 compared with wild-type mice

• however, treatment with anti-TNF-alpha antibodies reduces induced arthritis score and levels of TNF-alpha, IL6, and MMP3

homeostasis/metabolism

increased circulating interleukin-1 beta level ( J:159504 )

• following treatment with anti-CII antibodies

increased circulating interleukin-6 level ( J:159504 )

• following treatment with anti-CII antibodies

• however, treatment with anti-TNF-alpha antibodies reduces serum levels of IL6 induced by anti-CII antibodies

increased circulating tumor necrosis factor level ( J:159504 )

• following treatment with anti-CII antibodies

• however, treatment with anti-TNF-alpha antibodies reduces serum levels of TNF-alpha induced by anti-CII antibodies

hematopoietic system

abnormal T cell activation ( J:159504 )

• mice exhibit an increase in activated T cells compared with wild-type mice

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24